Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-06-17ELVN144Hohl Benjamin plan to sell securities of Enliven Therapeutics, Inc. under Form 144MEDIUM
Hohl Benjamin filed Form 144 to notify SEC of plan to sell 18054 units of Enliven Therapeutics, Inc. securities around 2026-06-17, with aggregate market value of $768,197.70. The total outstanding units is 60900000.0. The amount planned to be sold represents 0.03% of total outstanding units; ...
Mid CapBiotechnology
2026-06-17ANAB144DENNIS MULROY plan to sell securities of ANAPTYSBIO, INC. under Form 144MEDIUM
DENNIS MULROY filed Form 144 to notify SEC of plan to sell 850 units of ANAPTYSBIO, INC. securities around 2026-06-17, with aggregate market value of $51,000.00. The total outstanding units is 29100902.0. The amount planned to be sold represents 0.00% of total outstanding units; Recent transactions in past 3 months inc...
Small CapBiotechnology